🇺🇸 Omega-3 fatty acid capsules in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Tooth Loss — 1 report (100%)
Other Cardiovascular approved in United States
Frequently asked questions
Is Omega-3 fatty acid capsules approved in United States?
Omega-3 fatty acid capsules does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Omega-3 fatty acid capsules in United States?
Medical Center Alkmaar is the originator. The local marketing authorisation holder may differ — check the official source linked above.